The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics.
WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week. The new version, called Euvichol-S, is a simplified formula that uses fewer ingredients, is cheaper, and can be made more quickly than the old version.
The vaccine was shown to be help preventing the diarrheal disease in late stage research conducted in Nepal.
WHO’s approval means donor agencies like the vaccines alliance Gavi and UNICEF can now buy it for poorer countries. Leila Pakkala, director of UNICEF’s supply division, said in a statement that the agency will be able to boost supplies by more than 25%.
Arkansas Supreme Court says new DNA testing can be sought in 'West Memphis 3' case
Healthier School Meals Help Rural Students Grow
China Reaches First Women's Basketball World Cup Semifinals in 28 Years
In Pics: Chinese Elderly Enjoy Retired Life
Caitlin Clark and Angel Reese are OVERPAID at $75k
Media Center for 20th CPC National Congress to Open on Oct. 12
Beijing Sets up Fever Clinics in All Community Health Service Centers
Across China: Internet Hospitals Facilitate Medical Treatment
Dropping the ball: Jags hope to end decades of ineptitude when it comes to drafting receivers early
China Issues Guideline to Strengthen Conservation of Water, Soil
With Anthony Richardson on board, Colts will look beyond quarterback in NFL draft
Chinese Authorities Emphasize Assistance to People Facing Unexpected Financial Hardships